Brief: Sutro Biopharma announces operational restructuring intended to extend cash runway
29/09/2025 23:27
Sept 29 (Reuters) - Sutro Biopharma Inc STRO.O: SUTRO BIOPHARMA ANNOUNCES OPERATIONAL RESTRUCTURING INTENDED TO EXTEND CASH RUNWAY THROUGH KEY MILESTONES SUTRO BIOPHARMA INC - RESTRUCTURING TO RESULT IN WORKFORCE REDUCTION OF ONE-THIRD OF EMPLOYEES SUTRO BIOPHARMA INC - RESTRUCTURING EXPECTED TO EXTEND CASH RUNWAY INTO MID-2027 SUTRO BIOPHARMA INC - ANNOUNCES RESTRUCTURING TO PRIORITIZE ADC PROGRAMS SUTRO BIOPHARMA INC - ON TRACK TO ADVANCE STRO-004 INTO CLINIC THIS YEAR, DATA EXPECTED 2026 Source text: ID:nGNX6GxLQr Further company coverage: STRO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates